Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate Impact on the Reservoir of HIV
NCT07216794Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alendronate in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2026; status: recruiting.
02
Drugs
alendronate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07216794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07216794.